![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
This conference scene outlines a selection of sessions, which deals with the field of pharmacogenomics, held at the 78th Annual meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT), which took place from 19–22 March 2012 in Dresden, Germany. The DGPT is a registered society that represents the organization of three associations: the German Society for Pharmacology (dgp), the German Society for Clinical Pharmacology and Therapy (DGKliPha) and the German Society for Toxicology (gt). The conference represents a platform for intensive dialogues within and between the different disciplines covering basic science, the identification and understanding of new drug targets, the wide field of pharmaco- and toxico-genomics, drug regulation and toxicological risk assessment, as well as future advancements of new technologies.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.